Cintas (CTAS) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
10 Jan, 2026Executive summary
Second quarter revenue reached $2.56 billion, up 7.8% year-over-year, with organic growth of 7.1% and positive acquisition impact.
Net income rose 19.7% to $448.5 million, and diluted EPS increased 21.1% to $1.09, reflecting a recent four-for-one stock split.
Operating income margin improved to 23.1% from 21.0% year-over-year, driven by operational excellence and efficiency gains.
Gross margin expanded by 180 basis points to 49.8%, marking an all-time high for a quarter.
Quarterly dividend paid increased 14.9% year-over-year to $158.0 million.
Financial highlights
Six-month revenue grew 7.3% to $5.06 billion, with net income up 18.5% to $900.5 million and diluted EPS up 19.7% to $2.19 year-over-year.
Gross margin for the quarter was $1.28 billion (49.8% of revenue), and net income margin for Q2 was 17.5%, up from 15.8% a year ago.
Operating income for the six months was $1.15 billion, or 22.8% of revenue, up from 21.2% in the prior year period.
Free cash flow for the first six months increased 34.9% year-over-year.
Cash flow from operations was $908.1 million for the six months, up from $729.6 million year-over-year.
Outlook and guidance
Fiscal 2025 revenue guidance updated to $10.255–$10.32 billion, reflecting 6.9%–7.5% total growth and organic growth of 7.0%–7.7%.
Annual diluted EPS guidance raised to $4.28–$4.34, a 12.9%–14.5% increase.
Effective tax rate for fiscal 2025 expected at 20.2%.
Guidance assumes no future acquisitions, share buybacks, or major economic disruptions.
Management expects continued sufficient liquidity and access to $2.0 billion in revolving credit.
Latest events from Cintas
- Record Q3 revenue and margins, raised outlook, UniFirst deal, and strong capital returns.CTAS
Q3 202625 Mar 2026 - $5.5B merger delivers $375M synergies, $310/share for UniFirst, closing in H2 2026.CTAS
M&A announcement11 Mar 2026 - Record growth, margin expansion, and a four-for-one stock split highlight strong 2025 outlook.CTAS
Q4 20243 Feb 2026 - Revenue and profit surged, margins expanded, and guidance was raised for fiscal 2025.CTAS
Q1 202520 Jan 2026 - Directors and key proposals were voted on, with all board and management recommendations approved.CTAS
AGM 202418 Jan 2026 - Record revenue, margin expansion, and raised guidance highlight strong quarterly performance.CTAS
Q2 20267 Jan 2026 - Q3 revenue and EPS surged, driving higher guidance and strong margin expansion.CTAS
Q3 20256 Jan 2026 - Directors, executive pay, and auditors approved; special meeting proposal rejected; growth plans highlighted.CTAS
AGM 202514 Dec 2025 - Annual meeting covers director elections, pay, equity plan, auditor, and key ESG shareholder proposals.CTAS
Proxy Filing1 Dec 2025